Patients with type 1 diabetes are at elevated risk of developing new hypertension, chronic kidney disease and diabetic ketoacidosis after <scp>COVID</scp> ‐19: Up to 40 months’ follow‐up
T1D patients with COVID-19 are at higher risk of developing new HTN, CKD and DKA compared to T1D patients without COVID-19.
Authors
- Timothy Q. Duong (ORCID: https://orcid.org/0000-0001-6403-2827)
- Stephen Wang (ORCID: https://orcid.org/0000-0002-6212-2906)
- Montek Singh Boparai
- Justin Lu (ORCID: https://orcid.org/0000-0001-5715-9619)
- Sonya Henry (ORCID: https://orcid.org/0000-0002-6471-4569)
- Shiv Mehrotra‐Varma (ORCID: https://orcid.org/0009-0001-0748-3514)
Institutions
- Albert Einstein College of Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1111/dom.15900
- Citations
- 16
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 8.81